Detection of prostate-specific antigen immunoreactivity in amniotic fluid

Area of Science:

• Reproductive biology
• Biochemistry
• Prenatal diagnostics

Background:

• Prostate-specific antigen (PSA) is a protein primarily associated with the prostate gland.
• Its presence and role in fetal development are not fully understood.
• Recent literature suggests PSA may play a role in fetal growth regulation.

Purpose of the Study:

• To determine if PSA is present in amniotic fluid.
• To investigate changes in amniotic fluid PSA concentration with advancing gestational age.
• To explore any potential association between amniotic fluid PSA levels and fetal sex.

Main Methods:

• Amniotic fluid samples were collected from 48 pregnant women at two different gestational stages (16-18 weeks and >36 weeks).
• PSA concentrations were quantified using established laboratory assays.
• Statistical analyses were performed to compare PSA levels based on gestational age and fetal sex.

Main Results:

• PSA was detected in all tested amniotic fluid samples.
• Median PSA levels were higher in later-term samples (0.39 ng/ml at >36 weeks) compared to earlier samples (0.193 ng/ml at 16-18 weeks), though not statistically significant (p=0.1).
• No significant correlation was found between amniotic fluid PSA levels and fetal sex (p=0.72).

Conclusions:

• The findings support the hypothesis that PSA is present in amniotic fluid and may function as a growth regulator during normal fetal development.
• Further research is warranted to fully elucidate the precise functions of PSA in the prenatal environment.
• PSA's role in fetal development warrants continued investigation.